FDA reviews new painkiller

Share this article:

The FDA is set to review another drug that could join the prescription painkiller mix today. NPR reports that the latest pain reliever combines morphine and oxycodone. The all-in-one medication called Moxduo would be the first to combine the two pain relievers.

COO of drugmaker QRXPharma Ed Rudnic tells NPR that patients end up taking less of each drug with this medication than they would if prescribed both separately.

Painkillers have become a hot topic among lawmakers and addiction specialists because of a rise in opioid abuse. Massachusetts recently tried to ban opioid Zohydro in an effort to curb opioid abuse, but a court found the ban was unconstitutional.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.